Bringing innovative products to healthcare professionals

Established in 2011, Goddres Pharmaceutical Pvt Limited is an evolving pharmaceutical company with an active interest in women’s healthcare, orthopedics, critical care and gastroenterology. The company seeks to create brands based on innovation. They shape their strategies and purpose based on the needs of the end users and work on a product to meet the need. They are committed to bringing innovative, quality products for healthcare professionals to improve people’s well-being. Not only do they do research and development, but they also transfer knowledge to patients and caregivers.

Their goal is to become the most valued pharmaceutical partner of the World Pharma fraternity by continuously researching, developing and offering a wide range of pharmaceutical products that meet global standards and gaps in needs. Currently, they have products that cover three therapeutic areas: osteoporosis, peptic disorders, and iron deficiency anemia. These products are innovative in that they bridge the gap between the needs of the respective therapy.

Goddres is committed to providing innovative products and supporting the medical fraternity for academic and scientific needs. “We always support programs and initiatives that have a positive impact on treatment outcomes. We are actively present in four therapeutic segments: Gynecology, Orthopaedics, Critical Care and General Wellness,” says Gourango Mukherjee, CEO of Goddres Pharmaceutical.

About the CEO

Gourango Mukherjee, CEO and founding member of Goddres, is a veteran of the pharmaceutical industry. He spent over 30 years helping different companies achieve the coveted “Top 10” spot before launching Goddres Pharmaceuticals with a few other like-minded partners. He actively seeks new innovations and applications that can solve various medical problems. He always expresses his willingness to take risks and efforts to create positive changes in the pharmaceutical industry.

Turn challenges into opportunities

The lingering impacts of COVID-19 have had serious consequences for the industry, as consumer confidence is lower than usual demand for pharmaceuticals. Additionally, customer purchasing power remained weak as unemployment continued to be a challenge. Their inability to reach doctors and chemists led the company to adapt online modes such as E-CMEs, webinars and online group meetings, and KOL talk shows. They created an online training platform with an interactive interface for all their employees. The infrastructure was provided by a leading American technology company with the latest world-class hardware for the best virtual experience and effective training.

He says, “The demand forecasting challenge has also been adversely affected due to fluctuating demand and supply of printed raw materials and packaging materials. Thus, we have appointed two suppliers for each material to avoid shortages or delays. We also offered high incentives to buyers in case of low demand. »

During the pandemic, the company had to use the costly logistics mode of airmail to ensure timely delivery of supplies. They have also ensured that there is no shortage of drugs in the market. To run their production line, they paid high wages.

They have introduced generic products for the treatment of Covid and related products like Isopropyl hand sanitizer etc. With the prospect of increasing market share, they adopted stricter product quality control, good manufacturing compliance and import of key ingredients from the EU. They are having virtual meetings with doctors and strengthening their intensive care division.

The company uses new era technologies like AI/ML to address the various challenges of the pharmaceutical industry, such as automating and optimizing manufacturing processes, designing effective marketing and post-launch strategies. “Patient identification is a crucial step in the drug discovery and development process, especially for the conduct of clinical trials. AI simplifies the identification of eligibility criteria, the inclusion of patients, and also speeds up the process of identifying cohorts,” he explains.

They explore new ways of manufacturing. The flexible single-use production technology helps reduce downtime and increase productivity by eliminating complex steps such as cleaning and validation between different production stages.

Future plans

Goddres is one of India’s leading providers of clinically differentiated medicines. They are aware of the competitive market landscape, expansion opportunities, emerging therapies and maintain high social responsibility. “Our strategy is rooted in promoting scientific excellence and empowering scientists to create breakthroughs in the life sciences that will make a difference tomorrow. We strongly believe in the enormous potential of translating science into therapies that reduce human suffering and help people live longer, healthier lives. We are intensely focused on building unique drug delivery systems, especially in the area of ​​women’s health, ortho and GIT disorder management,” he says.

Articles under “Fortune India Exchange” are either infomercials or advertisements. Fortune India’s editorial staff or reporters are not involved in the writing or production of these articles.

Comments are closed.